Evidenced-Based Treatment of Posttraumatic Stress Disorder: An Updated Review of Validated Psychotherapeutic and Pharmacological Approaches

被引:45
作者
Charney, Meredith E. [1 ]
Hellberg, Samantha N.
Bui, Eric [1 ]
Simon, Naomi M. [1 ]
机构
[1] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA USA
关键词
behavior therapy; cognitive therapy; drug therapy; randomized controlled trials; stress disorders; post-traumatic; COGNITIVE-PROCESSING THERAPY; RANDOMIZED CONTROLLED-TRIAL; EYE-MOVEMENT DESENSITIZATION; BRIEF ECLECTIC PSYCHOTHERAPY; NARRATIVE EXPOSURE THERAPY; VENLAFAXINE EXTENDED-RELEASE; D-CYCLOSERINE AUGMENTATION; VIRTUAL-REALITY EXPOSURE; PROLONGED EXPOSURE; BEHAVIORAL-THERAPY;
D O I
10.1097/HRP.0000000000000186
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
A strong evidence base exists for psychological and pharmacological interventions for the treatment of posttraumatic stress disorder (PTSD). The published literature investigating the effectiveness of these treatments in reducing the symptoms and impairments associated with PTSD has expanded substantially in recent years. This review provides a concise overview of the empirical literature examining these treatment approaches. Evidence-based, trauma-focused therapies are recommended as first-line interventions, with the most support for cognitive- and exposure-based approaches. Prolonged exposure and cognitive processing therapy are the two most cited and rigorously investigated. Various other evidence-supported protocols are discussed. Pharmacotherapies can be used when evidence-based psychotherapies are not available or are ineffective, or on the basis of patient preference. Pharmacotherapy with the most support for PTSD includes selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors. Evidence supports the implementation of these interventions across genders, populations, and settings. Given that little research directly compares the effectiveness of different PTSD interventions and their mechanisms of action, it remains uncertain how to best select and tailor treatments to optimize individual outcomes. Future directions and novel, ongoing research are discussed.
引用
收藏
页码:99 / 115
页数:17
相关论文
共 148 条
[1]   A non-inferiority trial of Prolonged Exposure for posttraumatic stress disorder: In person versus home-based telehealth [J].
Acierno, Ron ;
Knapp, Rebecca ;
Tuerk, Peter ;
Gilmore, Amanda K. ;
Lejuez, Carl ;
Ruggiero, Kenneth ;
Muzzy, Wendy ;
Egede, Leonard ;
Hernandez-Tejada, Melba A. ;
Foa, Edna B. .
BEHAVIOUR RESEARCH AND THERAPY, 2017, 89 :57-65
[2]   Narrative exposure therapy for PTSD increases top-down processing of aversive stimuli - evidence from a randomized controlled treatment trial [J].
Adenauer, Hannah ;
Catani, Claudia ;
Gola, Hannah ;
Keil, Julian ;
Ruf, Martina ;
Schauer, Maggie ;
Neuner, Frank .
BMC NEUROSCIENCE, 2011, 12
[3]   A review of atypical antipsychotic medications for posttraumatic stress disorder [J].
Ahearn, Eileen P. ;
Juergens, Timothy ;
Cordes, Timothy ;
Becker, Tara ;
Krahn, Dean .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2011, 26 (04) :193-200
[4]  
American Psychological Association, 2017, Clinical practice guideline for the treatment of posttraumatic stress disorder
[5]  
[Anonymous], PSYCHOTHERAPY POSTTR
[6]  
[Anonymous], TREATM POSTTR STRESS
[7]  
[Anonymous], 2016, PRIM CARE COMPANION
[8]  
[Anonymous], PHARMACOTHERAPY POST
[9]  
[Anonymous], COMM ASS ONG EFF TRE
[10]  
[Anonymous], 2009, Full catastrophe living: Using the wisdom of your body and mind to face stress, pain, and illness